Literature DB >> 17200842

First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey.

F B Comert1, C Kulah, E Aktas, N Ozlu, G Celebi.   

Abstract

Reported here is the first isolation of vancomycin-resistant Enterococcus (VRE) at a hospital in northwestern Turkey and a description of the ensuing outbreak investigation. The first isolate was obtained from a wound culture of a patient in an intensive care unit. Thereafter, a total of 205 rectal swabs, 67 skin swabs and 123 environmental samples were screened, revealing five more VRE isolates. All isolates showed similar antibiotic resistance patterns, except for two that differed regarding gentamicin resistance. The vanA gene was present in all isolates. Pulsed-field gel electrophoresis demonstrated that all isolates belonged to a single clone, with the gentamicin-resistant isolates demonstrating two-band differences. This is the first outbreak to be caused by spread of a single VRE clone in Turkey; it was successfully controlled by strict adherence to appropriate infection control practices.

Entities:  

Mesh:

Year:  2007        PMID: 17200842     DOI: 10.1007/s10096-006-0232-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  The epidemiology of vancomycin-resistant enterococci.

Authors:  H Goossens
Journal:  Curr Opin Infect Dis       Date:  1999-12       Impact factor: 4.915

3.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Prevalence of vancomycin-resistant enterococci in Europe.

Authors:  M A Schouten; J A Hoogkamp-Korstanje; J F Meis; A Voss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-11       Impact factor: 3.267

5.  Resistant enterococci: prevalence and factors associated with colonization in a Turkish university hospital.

Authors:  C Ozkuyumcu
Journal:  Acta Microbiol Pol       Date:  1999

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Antimicrobial resistance of enterococci in Turkey.

Authors:  Birgül Kaçmaz; Altan Aksoy
Journal:  Int J Antimicrob Agents       Date:  2005-06       Impact factor: 5.283

8.  The prevalence of fecal colonization of enterococci, the resistance of the isolates to ampicillin, vancomycin, and high-level aminoglycosides, and the clonal relationship among isolates.

Authors:  Cigdem Kuzucu; Zeynep Cizmeci; Riza Durmaz; Bengul Durmaz; Ibrahim Halil Ozerol
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

9.  First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey.

Authors:  Dilek Colak; Thierry Naas; Filiz Gunseren; Nicolas Fortineau; Dilara Ogunc; Meral Gultekin; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

10.  First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey.

Authors:  A Basustaoglu; H Aydogan; C Beyan; A Yalcin; S Unal
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

View more
  1 in total

1.  Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey.

Authors:  Selda Aslan; Elvan Caglar Citak; Reyhan Yis; Suleyman Degirmenci; Dilek Arman
Journal:  Indian J Microbiol       Date:  2011-08-13       Impact factor: 2.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.